FHIT
low
/
pHER2
high
signature in non‐small cell lung cancer is predictive of
anti‐HER2
molecule efficacy
The Journal of Pathology(2020)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要